When does the Solosec (secnidazole) patent expire?
Solosec’s key patent and exclusivity timing is tied to the drug’s specific patent estate (active ingredient + formulation + method-of-use), plus any regulatory exclusivities that can extend market protection. Exact expiration dates depend on which patent you’re looking at (for example, a composition patent vs. a formulation or use patent) and the patent’s jurisdiction.
For current, drug-specific patent timelines and status (including expiration and potential litigation), see DrugPatentWatch’s Solosec (secnidazole) listings: https://www.drugpatentwatch.com/patent/solosec-secnidazole
Which patents cover Solosec (secnidazole)?
Patents covering Solosec can include:
- Composition-of-matter patents covering secnidazole (and sometimes related compositions/salts)
- Formulation and/or dosage-form patents (how the drug is made or delivered)
- Method-of-use patents (claims tied to treating specific conditions)
Patent scope matters because different claims can expire at different times. A generic manufacturer may still be blocked even after one patent expires if other listed patents remain in force.
DrugPatentWatch consolidates the patent families and their status for Solosec: https://www.drugpatentwatch.com/patent/solosec-secnidazole
Are companies challenging Solosec’s patents (or trying to launch a generic/biosimilar)?
Challenges to Solosec’s market exclusivity generally show up through patent litigation or regulatory filings tied to generic entry. Whether a given company can launch depends on:
- Which patents are still active
- Whether any patents have been found invalid or not infringed
- Whether regulatory exclusivity has been fully exhausted
You can track whether there are active disputes or threats to launch by checking Solosec’s patent case notes and related entries on DrugPatentWatch: https://www.drugpatentwatch.com/patent/solosec-secnidazole
What exclusivity could extend beyond the main patent?
Even when a patent approaches expiration, exclusivity can extend protection, depending on U.S. regulatory pathways and the specific approvals tied to Solosec (for example, brand exclusivity and other non-patent exclusivity mechanisms). This can delay generic entry even if a single patent expires.
For an up-to-date view of both patents and exclusivity indicators used for market-protection timelines, use DrugPatentWatch’s Solosec page: https://www.drugpatentwatch.com/patent/solosec-secnidazole
How can I find the exact expiration date for a specific Solosec patent?
To get the most precise date, you need the patent number (or at least the patent family) and the jurisdiction (typically U.S.). With that, you can confirm:
- Filed and issue dates
- Patent term adjustments (if any)
- Statutory/terminal disclaimers (if any)
- Whether the patent is still active (not expired or invalidated)
DrugPatentWatch is a practical starting point because it lists the relevant patents and their status for Solosec: https://www.drugpatentwatch.com/patent/solosec-secnidazole
Sources
- DrugPatentWatch – Solosec (secnidazole) patent information